4//SEC Filing
Mack David Henry 4
Accession 0001415889-25-007071
CIK 0001699382other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:30 PM ET
Size
9.4 KB
Accession
0001415889-25-007071
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-03+800,000→ 800,000 totalExercise: $1.32Exp: 2035-03-03→ Common Stock (800,000 underlying)
Holdings
- 579,016
Common Stock
- 165,307(indirect: See footnote)
Common Stock
- 147,915(indirect: See footnote)
Common Stock
- 56,978(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Includes 27,097 shares acquired under the Issuer's Employee Stock Purchase Plan as follows: 2,777 shares acquired on May 20, 2021; 2,560 shares acquired on November 21, 2022; 10,023 shares acquired on November 20, 2023 and 11,737 shares acquired on November 20, 2024.
- [F2]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F3]The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F4]The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F5]Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.
Documents
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
Related Parties
1- filerCIK 0001341642
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:30 PM ET
- Size
- 9.4 KB